Dr. Jill M. Mazza, MD

Dr. Mazza practices at Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services.

Dr. Mazza's NPI, 1700049731, was assigned on July 9, 2008. Dr. Mazza graduated from Albany Medical College in 2008. Dr. Mazza's California license number on file is A113348.

Dr. Mazza's primary practice is Providence Saint Joseph Medical Center, at 501 South Buena Vista Street, Burbank, CA 91505 in Los Angeles County. The practice phone is (818) 843-5111.

Dr. Mazza's primary practice is Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services. The medical group on file is Providence Medical Institute. Dmand AI also links Dr. Mazza to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazza practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Mazza's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Mazza is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Mazza's licenses on file in 2 states: California and Maryland.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Mazza treats.

CMS data shows 1,010 Medicare services from Dr. Mazza across 9 procedure codes in 2024, for 466 Medicare patients. Medicare paid $62,445 for them. Every service was in an office.

CMS counts 466 Medicare patients who saw Dr. Mazza in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mazza's median patient age at 61, with 54% women.

In 2024, Dr. Mazza wrote 577 Medicare Part D claims for 249 patients. 88% of them were for generic drugs. CMS names the drug for 465 of them, across 16 drugs with 11 or more claims each, at $160,203 in total drug cost. In 2023, CMS named 537 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mazza for performance year 2024, reported individually. Dr. Mazza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mazza, published from 2012 to 2016. Dr. Mazza's most frequent co-authors are Sandra Lin, MD and Bozena Barbara Wrobel, MD.

CMS Open Payments shows 219 general payments to Dr. Mazza from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Intersect ENT, Inc. paid the most, $2,862.

Dr. Mazza graduated from Albany Medical College in 2008.

Dr. Mazza is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.